Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (211-220 of 687) with videos related to

Pageof 69
Sort By:
The American Journal of Cardiology|September 29, 2016
Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial)Batric Popovic, Nicolas Girerd, Patrick Rossignol, et al.
Journal of the American College of Cardiology|October 23, 2012
Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)Orly Vardeny, Dong Hong Wu, Akshay Desai, et al.
The American Journal of Cardiology|December 23, 2008
Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial, Ali Ahmed, Finn Waagstein, et al.
International Journal of Cardiology|March 27, 2007
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trialAli Ahmed, Bertram Pitt, Shahbudin H Rahimtoola, et al.
European Journal of Heart Failure|October 31, 2009
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trialChris Adamopoulos, Ali Ahmed, Renaud Fay, et al.
American Journal of Nephrology|September 4, 2017
Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or DiabetesAllan J Collins, Bertram Pitt, Nancy Reaven, et al.
European Heart Journal|June 1, 2007
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failureAli Ahmed, Faiez Zannad, Thomas E Love, et al.
European Journal of Heart Failure|April 8, 2014
Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trialJavaid Iqbal, Renaud Fay, David Adlam, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 7, 2021
Estimated plasma volume status in heart failure: clinical implications and future directionsMasatake Kobayashi, Nicolas Girerd, Kevin Duarte, et al.
Clinical Cardiology|October 27, 2006
Aldosterone blockade in post-acute myocardial infarction heart failureBertram Pitt, Roberto Ferrari, Mihai Gheorghiade, et al.
Pageof 69

Showing results (211-220 of 687) with videos related to

Sort By:
Pageof 69
The American Journal of Cardiology|September 29, 2016
Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial)Batric Popovic, Nicolas Girerd, Patrick Rossignol, et al.
Journal of the American College of Cardiology|October 23, 2012
Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)Orly Vardeny, Dong Hong Wu, Akshay Desai, et al.
The American Journal of Cardiology|December 23, 2008
Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial, Ali Ahmed, Finn Waagstein, et al.
International Journal of Cardiology|March 27, 2007
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trialAli Ahmed, Bertram Pitt, Shahbudin H Rahimtoola, et al.
European Journal of Heart Failure|October 31, 2009
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trialChris Adamopoulos, Ali Ahmed, Renaud Fay, et al.
American Journal of Nephrology|September 4, 2017
Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or DiabetesAllan J Collins, Bertram Pitt, Nancy Reaven, et al.
European Heart Journal|June 1, 2007
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failureAli Ahmed, Faiez Zannad, Thomas E Love, et al.
European Journal of Heart Failure|April 8, 2014
Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trialJavaid Iqbal, Renaud Fay, David Adlam, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 7, 2021
Estimated plasma volume status in heart failure: clinical implications and future directionsMasatake Kobayashi, Nicolas Girerd, Kevin Duarte, et al.
Clinical Cardiology|October 27, 2006
Aldosterone blockade in post-acute myocardial infarction heart failureBertram Pitt, Roberto Ferrari, Mihai Gheorghiade, et al.
Pageof 69